Document is current
Any future updates will be listed below
-
Authors
Abellanas, Miguel A. https://orcid.org/0000-0002-5680-1582
Purnapatre, Maitreyee
Burgaletto, Chiara https://orcid.org/0000-0002-5517-8223
Schwartz, Michal https://orcid.org/0000-0003-4015-7507
- License Information
-
More Information
Article History
Received: 20 September 2023
Accepted: 6 November 2024
First Online: 6 January 2025
Competing interests
: M.S. is an inventor of the intellectual property that forms the basis for the development of PD-L1 immunotherapy for AD. All other authors declare no competing interests.
